{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:03:09Z","timestamp":1792231389973,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T00:00:00Z","timestamp":1418083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00018-014-1798-6","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T14:56:54Z","timestamp":1418050614000},"page":"2023-2039","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-\u03b2\/Smad and ROS signaling"],"prefix":"10.1007","volume":"72","author":[{"given":"Sang-A","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Shin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ae","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Kee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Seok","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yhun Yhong","family":"Sheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,9]]},"reference":[{"issue":"5","key":"1798_CR1","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan D, Kim YO (2013) Evolving therapies for liver fibrosis. J Clin Investig 123(5):1887\u20131901","journal-title":"J Clin Investig"},{"issue":"2","key":"1798_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115(2):209\u2013218","journal-title":"J Clin Invest"},{"issue":"1","key":"1798_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1067-1927.2005.130102.x","volume":"13","author":"A Desmouliere","year":"2005","unstructured":"Desmouliere A, Chaponnier C, Gabbiani G (2005) Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 13(1):7\u201312","journal-title":"Wound Repair Regen"},{"issue":"4","key":"1798_CR4","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","volume":"275","author":"SL Friedman","year":"2000","unstructured":"Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275(4):2247\u20132250","journal-title":"J Biol Chem"},{"issue":"7","key":"1798_CR5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","volume":"18","author":"A Leask","year":"2004","unstructured":"Leask A, Abraham DJ (2004) TGF-\u03b2 signaling and the fibrotic response. FASEB J 18(7):816\u2013827","journal-title":"FASEB J"},{"issue":"1","key":"1798_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2009.09.026","volume":"48","author":"R-M Liu","year":"2010","unstructured":"Liu R-M, Gaston Pravia K (2010) Oxidative stress and glutathione in TGF-\u03b2-mediated fibrogenesis. Free Radic Biol Med 48(1):1\u201315","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"1798_CR7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massagu\u00e9 J (2003) Mechanisms of TGF-\u03b2 signaling from cell membrane to the nucleus. Cell 113(6):685\u2013700","journal-title":"Cell"},{"issue":"9","key":"1798_CR8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ncb434","volume":"9","author":"R Derynck","year":"2007","unstructured":"Derynck R, Akhurst RJ (2007) Differentiation plasticity regulated by TGF-\u03b2 family proteins in development and disease. Nat Cell Biol 9(9):1000\u20131004","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1798_CR9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cellsig.2012.10.003","volume":"25","author":"R Samarakoon","year":"2013","unstructured":"Samarakoon R, Overstreet JM, Higgins PJ (2013) TGF-\u03b2 signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities. Cell Signal 25(1):264\u2013268","journal-title":"Cell Signal"},{"key":"1798_CR10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","volume":"11","author":"R Akhurst","year":"2012","unstructured":"Akhurst R, Hata A (2012) Targeting the TGF\u03b2 signalling pathway in disease. Nat Rev Drug Discov 11:790\u2013811","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1798_CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2005.01192.x","volume":"26","author":"X Liu","year":"2006","unstructured":"Liu X, Hu H, Yin JQ (2006) Therapeutic strategies against TGF-\u03b2 signaling pathway in hepatic fibrosis. Liver International 26(1):8\u201322","journal-title":"Liver International"},{"key":"1798_CR12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev.pharmtox.45.120403.095906","volume":"45","author":"S Lotersztajn","year":"2005","unstructured":"Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A (2005) Hepatic fibrosis: molecular mechanisms and drug targets. Annu Rev Pharmacol Toxicol 45:605\u2013628","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"1798_CR13","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18(7):1028\u20131040","journal-title":"Nat Med"},{"issue":"6","key":"1798_CR14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/1535-7163.737.3.6","volume":"3","author":"MD Hjelmeland","year":"2004","unstructured":"Hjelmeland MD, Hjelmeland AB, Sathornsumetee S, Reese ED, Herbstreith MH, Laping NJ, Friedman HS, Bigner DD, Wang X-F, Rich JN (2004) SB-431542, a small molecule transforming growth factor-\u03b2-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol Cancer Ther 3(6):737\u2013745","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"1798_CR15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1124\/mol.65.3.744","volume":"65","author":"SD Byfield","year":"2004","unstructured":"Byfield SD, Major C, Laping NJ, Roberts AB (2004) SB-505124 is a selective inhibitor of transforming growth factor-\u03b2 type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol 65(3):744\u2013752","journal-title":"Mol Pharmacol"},{"issue":"15","key":"1798_CR16","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1158\/0008-5472.CAN-04-0018","volume":"64","author":"G Subramanian","year":"2004","unstructured":"Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M (2004) Targeting endogenous transforming growth factor \u03b2 receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype 1. Cancer Res 64(15):5200\u20135211","journal-title":"Cancer Res"},{"issue":"21","key":"1798_CR17","doi-asserted-by":"crossref","first-page":"7954","DOI":"10.1158\/0008-5472.CAN-04-1013","volume":"64","author":"M Uhl","year":"2004","unstructured":"Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu Y-W, Platten M, Herrlinger U (2004) SD-208, a novel transforming growth factor \u03b2 receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res 64(21):7954\u20137961","journal-title":"Cancer Res"},{"issue":"5","key":"1798_CR18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/1568011043352830","volume":"4","author":"T Sawyer","year":"2004","unstructured":"Sawyer T (2004) Novel oncogenic protein kinase inhibitors for cancer therapy. Curr Med Chem Anticancer Agents 4(5):449","journal-title":"Curr Med Chem Anticancer Agents"},{"issue":"2","key":"1798_CR19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.bjp.0706172","volume":"145","author":"AC Gouville","year":"2005","unstructured":"Gouville AC, Boullay V, Krysa G, Pilot J, Brusq JM, Loriolle F, Gauthier JM, Papworth SA, Laroze A, Gellibert F (2005) Inhibition of TGF-\u03b2 signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br J Pharmacol 145(2):166\u2013177","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1798_CR20","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1158\/0008-5472.CAN-10-2933","volume":"71","author":"L Zhou","year":"2011","unstructured":"Zhou L, McMahon C, Bhagat T, Alencar C, Yu Y, Fazzari M, Sohal D, Heuck C, Gundabolu K, Ng C (2011) Reduced SMAD7 leads to overactivation of TGF-\u03b2 signaling in MDS that can be reversed by a specific inhibitor of TGF-\u03b2 receptor I kinase. Cancer Res 71(3):955\u2013963","journal-title":"Cancer Res"},{"issue":"17","key":"1798_CR21","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.ejca.2011.07.007","volume":"47","author":"C-Y Park","year":"2011","unstructured":"Park C-Y, Son J-Y, Jin CH, Nam J-S, Kim D-K, Sheen YY (2011) EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung. Eur J Cancer 47(17):2642\u20132653","journal-title":"Eur J Cancer"},{"key":"1798_CR22","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1021\/jm500115w","volume":"57","author":"CH Jin","year":"2014","unstructured":"Jin CH, Krishnaiah M, Sreenu D, Subrahmanyam V, Rao K, Lee HJ, Park S-J, Park H-J, Lee K, Sheen YY (2014) Discovery of N-((4-([1, 2, 4] triazolo [1, 5-a] pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl) methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-\u03b2 type 1 receptor kinase as cancer immunotherapeutic\/antifibrotic agent. J Med Chem 57:4213\u20134238","journal-title":"J Med Chem"},{"issue":"3","key":"1798_CR23","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hep.23368","volume":"51","author":"K Taura","year":"2010","unstructured":"Taura K, Miura K, Iwaisako K, \u00d6sterreicher CH, Kodama Y, Penz-\u00d6sterreicher M, Brenner DA (2010) Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51(3):1027\u20131036","journal-title":"Hepatology"},{"key":"1798_CR24","first-page":"2013","volume":"0903","author":"JY Son","year":"2014","unstructured":"Son JY, Park S-Y, Kim S-J, Lee SJ, Park S-A, Kim M-J, Kim SW, Kim D-K, Nam J-S, Sheen YY (2014) EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis. Mol Cancer Ther 0903:2013","journal-title":"Mol Cancer Ther"},{"issue":"22","key":"1798_CR25","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3748\/wjg.v13.i22.3056","volume":"13","author":"F Verrecchia","year":"2007","unstructured":"Verrecchia F, Mauviel A (2007) Transforming growth factor-beta and fibrosis. World J Gastroenterol 13(22):3056\u20133062","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1798_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"T Wynn","year":"2008","unstructured":"Wynn T (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214(2):199\u2013210","journal-title":"J Pathol"},{"issue":"12","key":"1798_CR27","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/nm.3282","volume":"19","author":"NC Henderson","year":"2013","unstructured":"Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, Pellicoro A, Raschperger E, Betsholtz C, Ruminski PG (2013) Targeting of [alpha] v integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 19(12):1617\u20131624","journal-title":"Nat Med"},{"issue":"3","key":"1798_CR28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0098-2997(00)00004-2","volume":"21","author":"G Poli","year":"2000","unstructured":"Poli G (2000) Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21(3):49\u201398","journal-title":"Mol Aspects Med"},{"issue":"5","key":"1798_CR29","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/hep.24281","volume":"53","author":"YH Paik","year":"2011","unstructured":"Paik YH, Iwaisako K, Seki E, Inokuchi S, Schnabl B, \u00d6sterreicher CH, Kisseleva T, Brenner DA (2011) The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2\/gp91phox mediate hepatic fibrosis in mice. Hepatology 53(5):1730\u20131741","journal-title":"Hepatology"},{"issue":"12","key":"1798_CR30","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.freeradbiomed.2005.02.026","volume":"38","author":"SG Rhee","year":"2005","unstructured":"Rhee SG, Chae HZ, Kim K (2005) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38(12):1543\u20131552","journal-title":"Free Radic Biol Med"},{"key":"1798_CR31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","volume":"47","author":"TW Kensler","year":"2007","unstructured":"Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89\u2013116","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"1798_CR32","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","volume":"126","author":"R Issa","year":"2004","unstructured":"Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, Gaca MD, Sands E, Suliman I, Trim N, Knorr A (2004) Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 126(7):1795\u20131808","journal-title":"Gastroenterology"},{"issue":"5","key":"1798_CR33","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1053\/j.gastro.2011.01.040","volume":"140","author":"Y Popov","year":"2011","unstructured":"Popov Y, Sverdlov DY, Sharma AK, Bhaskar KR, Li S, Freitag TL, Lee J, Dieterich W, Melino G, Schuppan D (2011) Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice. Gastroenterology 140(5):1642\u20131652","journal-title":"Gastroenterology"},{"issue":"4","key":"1798_CR34","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","volume":"50","author":"Y Popov","year":"2009","unstructured":"Popov Y, Schuppan D (2009) Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 50(4):1294\u20131306","journal-title":"Hepatology"},{"issue":"8","key":"1798_CR35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","volume":"7","author":"SL Friedman","year":"2010","unstructured":"Friedman SL (2010) Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 7(8):425\u2013436","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"167","key":"1798_CR36","doi-asserted-by":"crossref","first-page":"167sr161","DOI":"10.1126\/scitranslmed.3004700","volume":"5","author":"SL Friedman","year":"2013","unstructured":"Friedman SL, Sheppard D, Duffield JS, Violette S (2013) Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med 5(167):167sr161","journal-title":"Sci Transl Med"},{"issue":"1","key":"1798_CR37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0300-483X(03)00157-4","volume":"189","author":"S Basu","year":"2003","unstructured":"Basu S (2003) Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients. Toxicology 189(1):113\u2013127","journal-title":"Toxicology"},{"issue":"3","key":"1798_CR38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1016-8478(23)17477-2","volume":"10","author":"K-Y Kim","year":"2000","unstructured":"Kim K-Y, Choi I, Kim S-S (2000) Progression of hepatic stellate cell activation is associated with the level of oxidative stress rather than cytokines during CCl4-induced fibrogenesis. Mol Cells 10(3):289\u2013300","journal-title":"Mol Cells"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-014-1798-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-014-1798-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-014-1798-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:42:26Z","timestamp":1747179746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-014-1798-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,9]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1798"],"URL":"https:\/\/doi.org\/10.1007\/s00018-014-1798-6","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,9]]}}}